Topic

Defitelio (defibrotide)

A collection of 30 issues

Work With Your Doctor to Get Defitelio (defibrotide) Approved by Blue Cross Blue Shield in Washington: Complete Prior Authorization Guide

Quick Answer: Defitelio (defibrotide) requires prior authorization from Blue Cross Blue Shield plans in Washington for hepatic VOD/SOS with organ dysfunction after HSCT. Success depends on partnering with your transplant team to document HSCT details, organ dysfunction, and meeting diagnostic criteria. Start by requesting your plan's Defitelio
6 min read

How to Get Defitelio (Defibrotide) Covered by Aetna CVS Health in Florida: Complete Prior Authorization and Appeals Guide

Quick Start: Getting Defitelio (Defibrotide) Approved by Aetna CVS Health in Florida Defitelio requires prior authorization from Aetna CVS Health for hepatic veno-occlusive disease (VOD) treatment following hematopoietic stem cell transplant. Your transplant team must document VOD using Baltimore or Cairo criteria plus organ dysfunction. Submit through Aetna's
5 min read

How to Get Defitelio (defibrotide) Covered by Aetna CVS Health in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Defitelio Covered by Aetna CVS Health in New Jersey Defitelio requires prior authorization from Aetna CVS Health for hepatic veno-occlusive disease (VOD) with organ dysfunction following stem cell transplant. Your transplant team must submit clinical documentation proving VOD diagnosis using Baltimore or Cairo criteria, plus evidence of
5 min read

How to Get Defitelio (defibrotide) Covered by Aetna CVS Health in Ohio: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Defitelio Covered by Aetna CVS Health in Ohio Defitelio (defibrotide) requires prior authorization from Aetna CVS Health for hepatic VOD/SOS with organ dysfunction post-HSCT. Your transplant team must submit comprehensive documentation including VOD/SOS diagnosis per Baltimore/Cairo criteria, evidence of renal or pulmonary dysfunction, and
7 min read

Get Defitelio (Defibrotide) Covered by Aetna CVS Health in New York: Prior Authorization Guide & Appeals Process

Answer Box: Getting Defitelio Covered by Aetna CVS Health in New York Defitelio (defibrotide) requires prior authorization from Aetna CVS Health for hepatic veno-occlusive disease (VOD)/sinusoidal obstruction syndrome (SOS) with organ dysfunction post-transplant. Key requirements: documented VOD/SOS diagnosis using Baltimore or Cairo criteria, evidence of renal or pulmonary
7 min read

How to Get Defitelio (Defibrotide) Covered by Humana in Illinois: PA Requirements, Appeals, and Cost Assistance

Quick Answer: Defitelio (defibrotide) requires prior authorization from Humana Medicare Advantage plans in Illinois for its FDA-approved use treating hepatic veno-occlusive disease (VOD/SOS) after stem cell transplantation. Your prescriber must submit documentation proving organ dysfunction and medical necessity. If denied, you have 65 days to appeal and can request
5 min read

How to Get Defitelio (Defibrotide) Covered by Humana in New York: PA Requirements, Appeals, and State Protections

Answer Box: Getting Defitelio (Defibrotide) Covered by Humana in New York Defitelio (defibrotide) requires prior authorization from Humana Medicare Advantage plans for hepatic veno-occlusive disease (VOD/SOS) with organ dysfunction post-HSCT. Coverage is limited to FDA-approved indication only. Fastest path to approval: Have your transplant physician submit PA request with
6 min read

How to Get Defitelio (defibrotide) Covered by Aetna CVS Health in Washington: Complete Prior Authorization Guide

Quick Answer: Defitelio (defibrotide) requires prior authorization from Aetna CVS Health for FDA-approved hepatic VOD/SOS treatment post-HSCT. Submit clinical documentation showing VOD diagnosis plus renal/pulmonary dysfunction through CVS Specialty Pharmacy. If denied, use Washington's external review process within 180 days. Start by gathering transplant records, diagnosis
5 min read